Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?

Overview ForecastFinancials Chart Transcripts

Cognition Therapeutics Ownership Summary

Cognition Therapeutics is owned by 25.06% institutional investors, 1.97% insiders, and 72.97% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 14.84% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.69% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cognition Therapeutics	25.06%	1.97%	72.97%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	6.00M	14.84%	$4.21M
Vanguard group	1.24M	3.07%	$868.94K
Sigma planning	614.49K	1.52%	$430.94K
Voss capital	500.00K	1.24%	$350.65K
Alyeska investment group	500.00K	1.24%	$350.65K
Geode capital management	352.35K	0.87%	$247.14K
American financial group	205.00K	0.51%	$143.77K
Cm management	200.00K	0.49%	$140.26K
Blackrock	152.58K	0.45%	$253.28K
Kestra advisory services	177.43K	0.44%	$124.43K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	6.00M	4.39%	$4.21M
Cm management	200.00K	0.13%	$140.26K
American financial group	205.00K	0.07%	$143.77K
Voss capital	500.00K	0.03%	$350.65K
Sigma planning	614.49K	0.01%	$430.94K
Castle wealth management	43.38K	0.01%	$30.42K
Fca corp /tx	51.47K	0.01%	$36.10K
Virtu financial	80.18K	0.00%	$56.00K
Bangor savings bank	34.02K	0.00%	$23.86K
Two sigma securities	13.74K	0.00%	$9.64K

Top Buyers

Holder	Shares	% Assets	Change
Bios capital management, lp	6.00M	4.39%	6.00M
Voss capital	500.00K	0.03%	500.00K
Sigma planning	614.49K	0.01%	417.30K
Blackrock	152.58K	-	96.76K
State street	121.85K	-	59.10K

Top Sellers

Holder	Shares	% Assets	Change
Awm investment company	-	-	-650.00K
Timelo investment management	-	-	-361.40K
Aigh capital management	-	-	-300.77K
Hohimer wealth management	-	-	-225.00K
Ubs group	41.11K	-	-156.75K

New Positions

Holder	Shares	% Assets	Change	Value
Bios capital management, lp	6.00M	4.39%	6.00M	$4.21M
Voss capital	500.00K	0.03%	500.00K	$350.65K
Envestnet asset management	30.00K	-	30.00K	$49.80K
Citadel advisors	26.95K	-	26.95K	$44.74K
Bryn mawr capital management	23.34K	0.00%	23.34K	$16.37K

Sold Out

Holder	Change
Opal wealth advisors	-500.00
Sandy spring bank	-2.00K
Qube research	-2.12K
Two sigma advisers, lp	-11.00K
Baird financial group	-22.39K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	30	-23.08%	10,129,593	138.12%	25	22.62%	13	-18.75%	6	50.00%
Sep 30, 2024	38	-17.39%	4,196,749	-20.97%	10	4.19%	15	-21.05%	4	-42.86%
Jun 30, 2024	46	-	5,310,353	-25.11%	15	3.56%	19	-24.00%	7	-12.50%
Mar 31, 2024	46	27.78%	7,090,800	-0.89%	21	3.70%	25	56.25%	8	300.00%
Dec 31, 2023	36	5.88%	7,154,655	0.15%	23	4.31%	16	128.57%	2	-60.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.01M	1.69%	-
Vanguard Institutional Extnd Mkt Idx Tr	200.58K	0.34%	-
Fidelity Extended Market Index	185.46K	0.30%	-1.18K
BlackRock Extended Equity Market K	64.70K	0.16%	-27.00
iShares Micro-Cap ETF	71.12K	0.11%	-
Extended Equity Market Fund K	64.02K	0.10%	196.00
Fidelity Total Market Index	59.10K	0.10%	-
Bridgeway Ultra-Small Company Market	31.87K	0.08%	-44.83K
Fidelity Series Total Market Index	45.43K	0.07%	-
Northern Trust Extended Eq Market Idx	19.06K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 31, 2025	Ricciardi Lisa	CEO & President	Buy	$30.00K
Mar 14, 2024	Ricciardi Lisa	CEO & President	Buy	$9.97K
Nov 29, 2022	RICHSTONE ELLEN B	-	Buy	$26.55K
Nov 28, 2022	Fletcher Aaron G.L.	-	Buy	$4.96K
Nov 28, 2022	Fletcher Aaron G.L.	-	Buy	$5.23K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	1	-
2024 Q2	-	-
2024 Q1	1	-
2023 Q4	-	-
2023 Q2	-	-

CGTX Ownership FAQ

Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 25.06%, followed by 1.97% insiders and 72.97% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 68.48%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 14.84%), Vanguard group (1.24M shares, 3.07%), and Sigma planning (614.49K shares, 1.52%). Together, they hold 19.43% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

Yes, BlackRock owns 0.45% of Cognition Therapeutics, totaling 152.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 253.28K$. In the last quarter, BlackRock increased its holdings by 96.76K shares, a 173.34% change.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.39% of its assets in 6M Cognition Therapeutics shares, valued at 4.21M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 1.69% of its total shares outstanding invested in 1.01M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools